Metrics PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
chronic obstructive pulmonary diseasesingle-inhaler triple therapyoutcomes researchepidemiologysimulation-based projection
• https://doi.org/10.36469/001c.55635 Pageviews and PDF downloads
Top Countries | |
---|---|
806 | |
134 | |
119 | |
101 | |
63 | |
58 | |
38 | |
36 | |
19 | |
18 |